查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1979981

生物科学电子市场预测至2034年：按产品类型、设备、应用、最终用户和地区分類的全球分析

Biosciences Electronics Market Forecasts to 2034 - Global Analysis By Product Type (Wearable Biosensors, Implantable Biosensors and Non-invasive Biosensors), Device, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的研究，预计到 2026 年，全球生物科学电子市场将达到 107.2 亿美元，在预测期内以 11.3% 的复合年增长率增长，到 2034 年将达到 252.3 亿美元。

生物电子学（生物科学电子学）是将生物学和电子学相结合，设计用于医疗、诊断和环境应用的高级装置的领域。它专注于开发感测器、穿戴式装置和植入，以实现生物讯号追踪、生理状态测量和精准医疗。生物组件与电子系统的整合能够实现即时监测、个人化医疗和改善临床疗效。这项技术在现代诊断、药物研发和生物技术领域中发挥着至关重要的作用，推动着精准医疗和智慧医疗创新，同时实现了生物平台和电子平台之间的无缝互动。

根据美国国立卫生研究院 (NIH) 的说法，生物电子医学被认为是一个很有前景的领域，它利用各种设备来调节神经迴路并治疗慢性疾病。 NIH 正在资助该领域的几项研究，包括迷走神经刺激 (VNS) 用于治疗自体免疫疾病和发炎性疾病。然而，NIH 并未正式定义类风湿性关节炎症状「减轻 30-50%」的具体意义。该数据并非 NIH 公布的统计数据。

对个人化医疗的需求日益增长

生物科学电子市场正受到个人化医疗日益增长的关注的显着影响。穿戴式和植入式生物电子设备能够持续监测个别健康指标，并支持客製化治疗策略。透过根据患者独特的生物学特征量身定制治疗方法，这些解决方案能够最大限度地减少副作用并改善治疗效果。临床医生和患者对个人化医疗的认识不断提高，推动了先进生物电子技术在诊断、慢性病管理和即时监测领域的应用。因此，随着医疗保健从标准化方法转向利用生物电子技术的患者个别化干预，该市场正经历显着增长。

生物电子设备高成本

生物电子设备的高成本对市场构成重大挑战。开发先进的可穿戴和植入式设备需要昂贵的材料、精密组件和复杂的製造工艺，因此难以以可承受的价格提供。高昂的价格限制了发展中地区和低收入患者群体获得这些设备的机会，阻碍了其广泛应用。医疗机构也可能因为缺乏成本效益证明而犹豫不决。此外，操作和维护方面的专业培训进一步增加了整体成本。因此，高昂的製造成本、部署成本和营运成本阻碍了生物电子解决方案的大规模应用，并减缓了全球市场的成长。

远端医疗和数位医疗保健的扩展

远端医疗和数位医疗的扩展为生物电子市场带来了巨大的成长潜力。穿戴式和远端监测生物电子设备能够向远端医疗系统提供即时患者讯息，从而实现远距离诊断和持续监测。这种整合有助于实现个人化护理，并减少患者就医次数。全球范围内数位医疗解决方案的日益普及预计将推动对生物电子设备的需求。此外，新兴市场远端医疗的发展创造了新的机会，并鼓励对经济高效、扩充性且互联互通的生物电子技术进行投资，以满足全球不同患者群体的需求。

市场参与者之间竞争激烈

市场参与企业之间的激烈竞争是生物电子产业面临的主要威胁。无论是老牌製造商或新兴Start-Ups，都在竞相推出先进的穿戴式装置、植入式装置和诊断设备。价格竞争、技术的快速变革以及强有力的行销策略迫使企业在控製成本的同时快速创新。小规模的公司难以满足这些需求，这可能导致市场整合。日益激烈的竞争正在挤压利润空间并阻碍产品普及，使得新参与企业和现有企业都难以在快速发展的生物电子领域中维持成长并保持竞争力。

新冠疫情的影响：

新冠疫情对生物电子市场造成了严重衝击，加速了穿戴式装置、远端监测系统和远端医疗平台的快速普及。保持社交距离的措施和医疗资源的紧张凸显了对慢性疾病患者和出现新冠症状者进行即时、非侵入性监测的必要性。各国政府和私营机构大力投资生物电子研发和数位医疗基础设施，以加强抗疫能力。儘管供应链挑战和生产延误暂时影响了市场，但疫情凸显了生物电子技术在远距离诊断、个人化医疗和数位医疗解决方案中的重要性，从而推动了市场的长期成长。

在预测期内，可穿戴生物感测器领域预计将占据最大的市场份额。

由于其便利性、非侵入性和持续监测健康指标的能力，穿戴式生物感测器领域预计将在预测期内占据最大的市场份额。健身追踪器、智慧型手錶和感测器贴片等设备能够即时追踪生命征象和其他生理数据，从而支援远端医疗并减少就医需求。人们对个人化医疗、慢性病管理和远端监测日益增长的兴趣正在推动对穿戴式装置的需求。与人工智慧、行动应用程式和云端系统的兼容性有助于提高患者参与度并实现数据驱动的医疗保健解决方案，使穿戴式生物感测器成为全球生物电子市场的主导细分领域。

在预测期内，居家医疗领域预计将呈现最高的复合年增长率。

在预测期内，受远端监测、个人化治疗和居家慢性病管理需求不断增长的推动，居家医疗领域预计将呈现最高的成长率。包括穿戴式和非侵入式感测器在内的生物电子设备，使患者无需频繁就医即可持续监测生命征象和其他健康指标，从而降低医疗成本。与远距远端医疗服务、行动应用程式和云端分析的整合，提高了患者参与度和护理效率。日益增强的健康意识、生物电子技术的进步以及老年人口的成长，正在推动居家医疗解决方案的快速普及，使其成为所有细分市场中成长率最高的领域。

市占率最大的地区：

在整个预测期内，北美预计将保持最大的市场份额，这得益于其完善的医疗保健基础设施和数位健康解决方案的广泛应用。强大的研发投入、领先的生物电子公司以及有利的监管政策正在推动穿戴式、植入式和非侵入式设备的开发和商业化。对个人化医疗、远端监测和慢性病管理日益增长的需求也促进了市场成长。生物电子技术与人工智慧、物联网和远端医疗平台的融合将提升医疗服务和病人参与。这些因素共同确保北美继续保持全球生物电子市场最大区域贡献者的地位。

复合年增长率最高的地区：

在预测期内，亚太地区预计将呈现最高的复合年增长率，这主要得益于医疗基础设施的不断改进、医疗支出的增加以及人们对创新医疗技术的日益关注。穿戴式装置、植入和非侵入式生物电子设备在远端监测和慢性病管理方面的应用正在加速。政府的支持政策、技术的进步以及远端医疗服务的扩展进一步刺激了市场需求。大规模的老龄人口和慢性病盛行率的上升创造了巨大的市场机会，使亚太地区成为全球生物电子产业成长最快的地区。

免费客製化服务：

购买此报告的客户可以选择以下免费自订选项之一：

  • 企业概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域细分
    • 主要国家的市场估算和预测，以及根据客户需求量身定制的复合年增长率（註：需要进行可行性测试）。
  • 竞争性标竿分析
    • 根据主要参与者的产品系列、地理覆盖范围和策略联盟进行基准分析。

目录

第一章：执行摘要

  • 市场概览及主要亮点
  • 驱动因素、挑战与机会
  • 竞争格局概述
  • 战略洞察与建议

第二章：研究框架

  • 研究目标和范围
  • 相关人员分析
  • 研究假设和限制
  • 调查方法

第三章 市场动态与趋势分析

  • 市场定义与结构
  • 主要市场驱动因素
  • 市场限制与挑战
  • 投资成长机会和重点领域
  • 产业威胁与风险评估
  • 技术与创新展望
  • 新兴市场/高成长市场
  • 监管和政策环境
  • 新冠疫情的影响及復苏前景

第四章：竞争环境与策略评估

  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的竞争
  • 主要企业市占率分析
  • 产品基准评效和效能比较

第五章 全球生物科学电子产品市场：依产品类型划分

  • 穿戴式生物感测器
  • 植入式生物感测器
  • 非侵入式生物感测器

第六章 全球生物科学电子市场：依设备划分

  • 生物电子设备
  • 生物电子医学
  • 生物电子技术

第七章 全球生物科学电子市场：依应用划分

  • 卫生保健
  • 环境监测
  • 食品安全
  • 工业应用

第八章：全球生物科学电子产品市场：依最终用户划分

  • 医院
  • 居家医疗
  • 研究所
  • 工业设施

第九章 全球生物科学电子市场：依地区划分

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 比利时
    • 瑞典
    • 瑞士
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 马来西亚
    • 新加坡
    • 越南
    • 其他亚太国家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他南美国家
  • 世界其他地区（RoW）
    • 中东
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 以色列
      • 其他中东国家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲国家

第十章 战略市场资讯

  • 工业价值网络和供应链评估
  • 空白区域和机会地图
  • 产品演进与市场生命週期分析
  • 通路、经销商和打入市场策略的评估

第十一章 产业趋势与策略倡议

  • 併购
  • 伙伴关係、联盟和合资企业
  • 新产品发布和认证
  • 扩大生产能力和投资
  • 其他策略倡议

第十二章：公司简介

  • Medtronic
  • Abbott Laboratories
  • Boston Scientific
  • Siemens Healthineers
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories
  • GE Healthcare
  • Thermo Fisher Scientific
  • Danaher Corporation
  • Salvia BioElectronics
  • Synchron
  • Cochlear Ltd
  • LivaNova PLC
  • BIOTRONIK
  • Nevro Corp
  • Nova Biomedical
  • Dexcom, Inc.
  • Analog Devices, Inc.
Product Code: SMRC34144

According to Stratistics MRC, the Global Biosciences Electronics Market is accounted for $10.72 billion in 2026 and is expected to reach $25.23 billion by 2034 growing at a CAGR of 11.3% during the forecast period. Bioelectronics, or biosciences electronics, merges biology with electronic engineering to design advanced devices for healthcare, diagnostics, and environmental applications. It emphasizes the development of sensors, wearables, and implants that track biological signals, measure physiological conditions, and administer precise treatments. Integrating biological components with electronic systems allows real-time monitoring, personalized therapies, and enhanced clinical outcomes. This technology plays a vital role in modern diagnostics, pharmaceutical research, and biotechnology, promoting precision medicine and intelligent healthcare innovations while creating seamless interactions between living organisms and electronic platforms.

According to the National Institutes of Health (NIH), bioelectronic medicine is recognized as a promising field that uses devices to modulate neural circuits for treating chronic diseases. NIH has funded multiple studies in this area, including vagus nerve stimulation (VNS) for autoimmune and inflammatory conditions. However, NIH does not officially state a fixed "30-50% reduction" figure in rheumatoid arthritis symptoms. That number is not an NIH-published statistic.

Market Dynamics:

Driver:

Rising demand for personalized healthcare

The biosciences electronics market is strongly influenced by the rising focus on personalized healthcare. Wearable and implantable bioelectronic devices enable continuous monitoring of individual health metrics, supporting customized treatment strategies. By adjusting therapies according to a patient's unique biological profile, these solutions minimize side effects and improve outcomes. Growing awareness of personalized care among clinicians and patients is driving the adoption of advanced bioelectronics in diagnostics, chronic illness management, and real-time monitoring. Consequently, the market experiences significant growth as healthcare transitions from standard approaches to patient-specific interventions that leverage bioelectronic technology.

Restraint:

High cost of bioelectronic devices

The expensive nature of bioelectronic devices poses a major challenge to the market. Developing advanced wearable and implantable devices involves costly materials, precision components, and intricate manufacturing, making them less affordable. High prices restrict access in developing regions and among patients with limited income, curbing adoption. Healthcare providers may also be reluctant to invest without demonstrable cost-effectiveness. Additionally, specialized training for operation and maintenance adds to the overall expense. As a result, the high production, implementation, and operational costs hinder the large-scale deployment of bioelectronics solutions and slow overall market growth worldwide.

Opportunity:

Expansion of telemedicine and digital health

The expansion of telemedicine and digital healthcare offers substantial growth potential for the biosciences electronics market. Wearable and remote monitoring bioelectronic devices can feed real-time patient information into telehealth systems, facilitating remote diagnostics and continuous monitoring. This integration allows for personalized care and reduces the need for hospital visits. Increasing adoption of digital health solutions globally is expected to drive demand for bioelectronics devices. Additionally, the growth of telemedicine in emerging markets creates new opportunities, promoting investment in cost-effective, scalable, and connected bioelectronic technologies that cater to diverse patient populations worldwide.

Threat:

Intense competition among market players

High competition among market participants is a major threat to the biosciences electronics industry. Both established manufacturers and emerging startups are vying to launch advanced wearable, implantable, and diagnostic devices. Competitive pricing, fast technological changes, and strong marketing tactics force companies to innovate rapidly while managing costs. Smaller firms may find it difficult to meet these demands, potentially leading to consolidation in the market. Increased rivalry can compress profit margins and hinder adoption rates, making it challenging for new entrants and existing players to sustain growth and remain competitive in the rapidly evolving bioelectronics sector.

Covid-19 Impact:

The COVID-19 outbreak had a profound impact on the biosciences electronics market, driving rapid adoption of wearable devices, remote monitoring systems, and telemedicine platforms. Social distancing measures and stressed healthcare facilities increased the need for real-time, non-invasive monitoring of patients with chronic conditions and COVID-19 symptoms. Governments and private organizations invested heavily in bioelectronics R&D and digital health infrastructure to improve pandemic response. Although supply chain challenges and production delays temporarily affected the market, the pandemic ultimately highlighted the importance of bioelectronics in remote diagnostics, personalized healthcare, and digital health solutions, fostering long-term market growth.

The wearable biosensors segment is expected to be the largest during the forecast period

The wearable biosensors segment is expected to account for the largest market share during the forecast period due to their convenience, non-invasive nature, and ability to offer continuous monitoring of health metrics. Devices like fitness trackers, smartwatches, and sensor patches enable real-time tracking of vital signs and other physiological data, supporting remote healthcare and reducing the need for hospital visits. Rising emphasis on personalized medicine, chronic disease management, and remote monitoring has boosted demand for wearable devices. Their compatibility with AI, mobile apps, and cloud systems enhances patient engagement and enables data-driven healthcare solutions, making wearable biosensors the leading segment in the global bioelectronics market.

The home healthcare segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the home healthcare segment is predicted to witness the highest growth rate due to increasing demand for remote monitoring, personalized treatment, and chronic disease management at home. Bioelectronic devices, including wearable and non-invasive sensors, allow patients to continuously track vital signs and other health metrics without frequent hospital visits, lowering healthcare expenses. Their connection with telehealth services, mobile applications, and cloud analytics improves patient participation and care effectiveness. Rising health awareness, advancements in bioelectronics technology, and a growing elderly population are driving the accelerated adoption of home healthcare solutions, resulting in the highest growth rate among all market segments.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, attributed to its well-established healthcare infrastructure and widespread adoption of digital health solutions. Strong R&D investment, presence of leading bioelectronics companies, and supportive regulatory policies encourage the development and commercialization of wearable, implantable, and non-invasive devices. Rising demand for personalized healthcare, remote monitoring, and management of chronic diseases also contributes to market growth. Integration of bioelectronics with AI, IoT, and telemedicine platforms enhances healthcare delivery and patient engagement. These factors collectively ensure that North America remains the largest regional contributor to the global bioelectronics market.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by enhancements in healthcare infrastructure, increased spending, and greater awareness of innovative medical technologies. The adoption of wearable, implantable, and non-invasive bioelectronic devices for remote monitoring and chronic condition management is accelerating. Supportive government policies, advances in technology, and the expansion of telehealth services further stimulate demand. A large, aging population and increasing chronic disease prevalence create substantial market opportunities, positioning Asia-Pacific as the fastest-growing region in the global biosciences electronics industry.

Key players in the market

Some of the key players in Biosciences Electronics Market include Medtronic, Abbott Laboratories, Boston Scientific, Siemens Healthineers, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific, Danaher Corporation, Salvia BioElectronics, Synchron, Cochlear Ltd, LivaNova PLC, BIOTRONIK, Nevro Corp, Nova Biomedical, Dexcom, Inc. and Analog Devices, Inc.

Key Developments:

In February 2026, Medtronic has agreed to acquire CathWorks, an Israeli medtech company focused on the diagnosis and treatment of coronary artery disease, for up to $585 million. CathWorks is known for its FFRangio technology, which uses advanced artificial intelligence (AI) algorithms and computational science to obtain fractional flow reserve (FFR) measurements of the coronary tree from routine X-ray images.

In January 2026, Boston Scientific Corporation and Penumbra, Inc. announced the companies have entered into a definitive agreement under which Boston Scientific will acquire Penumbra in cash and stock transaction that values Penumbra at $374 per share, reflecting an enterprise value of approximately $14.5 billion.

In November 2025, Abbott and Exact Sciences announced a definitive agreement for Abbott to acquire Exact Sciences, which will enable it to enter and lead in fast-growing cancer diagnostics segments, serving millions more people. Under the terms of the agreement, Exact Sciences shareholders will receive $105 per common share, representing a total equity value of approximately $21 billion.

Product Types Covered:

  • Wearable Biosensors
  • Implantable Biosensors
  • Non-invasive Biosensors

Devices Covered:

  • Bio-electronic Devices
  • Bio-electronic Medicine
  • Bio-electronic Technology

Applications Covered:

  • Healthcare
  • Environmental Monitoring
  • Food Safety
  • Industrial Applications

End Users Covered:

  • Hospitals
  • Home Healthcare
  • Research Laboratories
  • Industrial Facilities

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Biosciences Electronics Market, By Product Type

  • 5.1 Wearable Biosensors
  • 5.2 Implantable Biosensors
  • 5.3 Non-invasive Biosensors

6 Global Biosciences Electronics Market, By Device

  • 6.1 Bio-electronic Devices
  • 6.2 Bio-electronic Medicine
  • 6.3 Bio-electronic Technology

7 Global Biosciences Electronics Market, By Application

  • 7.1 Healthcare
  • 7.2 Environmental Monitoring
  • 7.3 Food Safety
  • 7.4 Industrial Applications

8 Global Biosciences Electronics Market, By End User

  • 8.1 Hospitals
  • 8.2 Home Healthcare
  • 8.3 Research Laboratories
  • 8.4 Industrial Facilities

9 Global Biosciences Electronics Market, By Geography

  • 9.1 North America
    • 9.1.1 United States
    • 9.1.2 Canada
    • 9.1.3 Mexico
  • 9.2 Europe
    • 9.2.1 United Kingdom
    • 9.2.2 Germany
    • 9.2.3 France
    • 9.2.4 Italy
    • 9.2.5 Spain
    • 9.2.6 Netherlands
    • 9.2.7 Belgium
    • 9.2.8 Sweden
    • 9.2.9 Switzerland
    • 9.2.10 Poland
    • 9.2.11 Rest of Europe
  • 9.3 Asia Pacific
    • 9.3.1 China
    • 9.3.2 Japan
    • 9.3.3 India
    • 9.3.4 South Korea
    • 9.3.5 Australia
    • 9.3.6 Indonesia
    • 9.3.7 Thailand
    • 9.3.8 Malaysia
    • 9.3.9 Singapore
    • 9.3.10 Vietnam
    • 9.3.11 Rest of Asia Pacific
  • 9.4 South America
    • 9.4.1 Brazil
    • 9.4.2 Argentina
    • 9.4.3 Colombia
    • 9.4.4 Chile
    • 9.4.5 Peru
    • 9.4.6 Rest of South America
  • 9.5 Rest of the World (RoW)
    • 9.5.1 Middle East
      • 9.5.1.1 Saudi Arabia
      • 9.5.1.2 United Arab Emirates
      • 9.5.1.3 Qatar
      • 9.5.1.4 Israel
      • 9.5.1.5 Rest of Middle East
    • 9.5.2 Africa
      • 9.5.2.1 South Africa
      • 9.5.2.2 Egypt
      • 9.5.2.3 Morocco
      • 9.5.2.4 Rest of Africa

10 Strategic Market Intelligence

  • 10.1 Industry Value Network and Supply Chain Assessment
  • 10.2 White-Space and Opportunity Mapping
  • 10.3 Product Evolution and Market Life Cycle Analysis
  • 10.4 Channel, Distributor, and Go-to-Market Assessment

11 Industry Developments and Strategic Initiatives

  • 11.1 Mergers and Acquisitions
  • 11.2 Partnerships, Alliances, and Joint Ventures
  • 11.3 New Product Launches and Certifications
  • 11.4 Capacity Expansion and Investments
  • 11.5 Other Strategic Initiatives

12 Company Profiles

  • 12.1 Medtronic
  • 12.2 Abbott Laboratories
  • 12.3 Boston Scientific
  • 12.4 Siemens Healthineers
  • 12.5 F. Hoffmann-La Roche Ltd
  • 12.6 Bio-Rad Laboratories
  • 12.7 GE Healthcare
  • 12.8 Thermo Fisher Scientific
  • 12.9 Danaher Corporation
  • 12.10 Salvia BioElectronics
  • 12.11 Synchron
  • 12.12 Cochlear Ltd
  • 12.13 LivaNova PLC
  • 12.14 BIOTRONIK
  • 12.15 Nevro Corp
  • 12.16 Nova Biomedical
  • 12.17 Dexcom, Inc.
  • 12.18 Analog Devices, Inc.

List of Tables

  • Table 1 Global Biosciences Electronics Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Biosciences Electronics Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Biosciences Electronics Market Outlook, By Wearable Biosensors (2023-2034) ($MN)
  • Table 4 Global Biosciences Electronics Market Outlook, By Implantable Biosensors (2023-2034) ($MN)
  • Table 5 Global Biosciences Electronics Market Outlook, By Non-invasive Biosensors (2023-2034) ($MN)
  • Table 6 Global Biosciences Electronics Market Outlook, By Device (2023-2034) ($MN)
  • Table 7 Global Biosciences Electronics Market Outlook, By Bio-electronic Devices (2023-2034) ($MN)
  • Table 8 Global Biosciences Electronics Market Outlook, By Bio-electronic Medicine (2023-2034) ($MN)
  • Table 9 Global Biosciences Electronics Market Outlook, By Bio-electronic Technology (2023-2034) ($MN)
  • Table 10 Global Biosciences Electronics Market Outlook, By Application (2023-2034) ($MN)
  • Table 11 Global Biosciences Electronics Market Outlook, By Healthcare (2023-2034) ($MN)
  • Table 12 Global Biosciences Electronics Market Outlook, By Environmental Monitoring (2023-2034) ($MN)
  • Table 13 Global Biosciences Electronics Market Outlook, By Food Safety (2023-2034) ($MN)
  • Table 14 Global Biosciences Electronics Market Outlook, By Industrial Applications (2023-2034) ($MN)
  • Table 15 Global Biosciences Electronics Market Outlook, By End User (2023-2034) ($MN)
  • Table 16 Global Biosciences Electronics Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 17 Global Biosciences Electronics Market Outlook, By Home Healthcare (2023-2034) ($MN)
  • Table 18 Global Biosciences Electronics Market Outlook, By Research Laboratories (2023-2034) ($MN)
  • Table 19 Global Biosciences Electronics Market Outlook, By Industrial Facilities (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.